New drug fabhalta under safety watch for rare blood disorder

NCT ID NCT06606314

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tracks 132 people with PNH who are taking Fabhalta to see how safe it is and what side effects occur. Researchers will monitor infections and check for serious red blood cell breakdown if the drug is stopped. The goal is to better understand the drug's risks in everyday use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAROXYSMAL NOCTURNAL HEMOGLOBINURIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hemoglobinuria, Paroxysmal paroxysmal nocturnal hemoglobinuria

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Novartis Investigative Site

    Handa, Aichi-ken, 475-0817, Japan

  • Novartis Investigative Site

    Nagoya, Aichi-ken, 453-8511, Japan

  • Novartis Investigative Site

    Nagoya, Aichi-ken, 466-8650, Japan

  • Novartis Investigative Site

    Okazaki, Aichi-ken, 444-8553, Japan

  • Novartis Investigative Site

    Toyohashi, Aichi-ken, 441-8570, Japan

  • Novartis Investigative Site

    Toyota, Aichi-ken, 470-0343, Japan

  • Novartis Investigative Site

    Toyota, Aichi-ken, 471-8513, Japan

  • Novartis Investigative Site

    Hachinohe, Aomori, 0391104, Japan

  • Novartis Investigative Site

    Chiba, Chiba, 2608677, Japan

  • Novartis Investigative Site

    Funabashi, Chiba, 273-8556, Japan

  • Novartis Investigative Site

    Kashiwa, Chiba, 277-8567, Japan

  • Novartis Investigative Site

    Narita, Chiba, 286-8523, Japan

  • Novartis Investigative Site

    Matsuyama, Ehime, 790-8524, Japan

  • Novartis Investigative Site

    Fukuoka, Fukuoka, 810-8563, Japan

  • Novartis Investigative Site

    Kurume, Fukuoka, 830-8543, Japan

  • Novartis Investigative Site

    Aizu-Wakamatsu, Fukushima, 9693482, Japan

  • Novartis Investigative Site

    Kohriyama, Fukushima, 963-8022, Japan

  • Novartis Investigative Site

    Maebashi, Gunma, 371-0811, Japan

  • Novartis Investigative Site

    Fukuyama, Hiroshima, 720-0001, Japan

  • Novartis Investigative Site

    Hakodate, Hokkaido, 0410821, Japan

  • Novartis Investigative Site

    Sapporo, Hokkaido, 0030006, Japan

  • Novartis Investigative Site

    Sapporo, Hokkaido, 0640804, Japan

  • Novartis Investigative Site

    Amagasaki, Hyōgo, 660-8511, Japan

  • Novartis Investigative Site

    Ashiya, Hyōgo, 659-0012, Japan

  • Novartis Investigative Site

    Himeji, Hyōgo, 670-8540, Japan

  • Novartis Investigative Site

    Kobe, Hyōgo, 6500047, Japan

  • Novartis Investigative Site

    Kobe, Hyōgo, 651-0072, Japan

  • Novartis Investigative Site

    Nishinomiya, Hyōgo, 662-0918, Japan

  • Novartis Investigative Site

    Nishinomiya, Hyōgo, 6638501, Japan

  • Novartis Investigative Site

    Tsukuba, Ibaraki, 300-2622, Japan

  • Novartis Investigative Site

    Tsukuba, Ibaraki, 3058576, Japan

  • Novartis Investigative Site

    Tsukuba, Ibaraki, Ibaraki, Japan

  • Novartis Investigative Site

    Morioka, Iwate, 0200066, Japan

  • Novartis Investigative Site

    Sakaidechō, Kagawa-ken, 762-8550, Japan

  • Novartis Investigative Site

    Kanoya, Kagoshima-ken, 893-0024, Japan

  • Novartis Investigative Site

    Isehara, Kanagawa, 259-1193, Japan

  • Novartis Investigative Site

    Yokohama, Kanagawa, 232-0024, Japan

  • Novartis Investigative Site

    Kumamoto, Kumamoto, 860-8556, Japan

  • Novartis Investigative Site

    Kyoto, Kyoto, 603-8151, Japan

  • Novartis Investigative Site

    Uji, Kyoto, 611-0042, Japan

  • Novartis Investigative Site

    Ōsaki, Miyagi, 989-6183, Japan

  • Novartis Investigative Site

    Miyazaki, Miyazaki, 880-8510, Japan

  • Novartis Investigative Site

    Nobeoka, Miyazaki, 882-0835, Japan

  • Novartis Investigative Site

    Matsumoto, Nagano, 3908621, Japan

  • Novartis Investigative Site

    Nagano, Nagano, 3808582, Japan

  • Novartis Investigative Site

    Suwa, Nagano, 392-8510, Japan

  • Novartis Investigative Site

    Ōmura, Nagasaki, 856-8562, Japan

  • Novartis Investigative Site

    Ikoma, Nara, 630-0293, Japan

  • Novartis Investigative Site

    Nagaoka, Niigata, 940-2085, Japan

  • Novartis Investigative Site

    Beppu, Oita Prefecture, 874-0840, Japan

  • Novartis Investigative Site

    Uruma, Okinawa, 904-2293, Japan

  • Novartis Investigative Site

    Habikino, Osaka, 583-0872, Japan

  • Novartis Investigative Site

    Izumi, Osaka, 594-0071, Japan

  • Novartis Investigative Site

    Moriguchi, Osaka, 570-8540, Japan

  • Novartis Investigative Site

    Suita, Osaka, 565-0871, Japan

  • Novartis Investigative Site

    Saga, Saga-ken, 849-8501, Japan

  • Novartis Investigative Site

    Fukaya, Saitama, 366-0052, Japan

  • Novartis Investigative Site

    Kawagoe, Saitama, 3508550, Japan

  • Novartis Investigative Site

    Tokorozawa, Saitama, 359-0037, Japan

  • Novartis Investigative Site

    Hikone, Shiga, 522-0057, Japan

  • Novartis Investigative Site

    Ōtsu, Shiga, 520-0804, Japan

  • Novartis Investigative Site

    Rittō, Shiga, 520-3046, Japan

  • Novartis Investigative Site

    Iwata, Shizuoka, 438-8550, Japan

  • Novartis Investigative Site

    Shimotsuga Gun, Tochigi, 3210293, Japan

  • Novartis Investigative Site

    Shimotsuke, Tochigi, 329-0498, Japan

  • Novartis Investigative Site

    Utsunomiya, Tochigi, 321-0974, Japan

  • Novartis Investigative Site

    Bunkyo Ku, Tokyo, 1138431, Japan

  • Novartis Investigative Site

    Higashimurayama, Tokyo, 189-8511, Japan

  • Novartis Investigative Site

    Itabashi Ku, Tokyo, 1738606, Japan

  • Novartis Investigative Site

    Itabashi-ku, Tokyo, 1738610, Japan

  • Novartis Investigative Site

    Meguro City, Tokyo, 153-8581, Japan

  • Novartis Investigative Site

    Minato-ku, Tokyo, 105-8471, Japan

  • Novartis Investigative Site

    Nerima City, Tokyo, 113-0033, Japan

  • Novartis Investigative Site

    Nerima City, Tokyo, 179-0072, Japan

  • Novartis Investigative Site

    Ōta-ku, Tokyo, 1438541, Japan

  • Novartis Investigative Site

    Shibuya City, Tokyo, 150-8935, Japan

  • Novartis Investigative Site

    Shinagawa Ku, Tokyo, 1418625, Japan

  • Novartis Investigative Site

    Shinagawa-ku, Tokyo, 1428666, Japan

  • Novartis Investigative Site

    Shinjuku Ku, Tokyo, 160-0023, Japan

  • Novartis Investigative Site

    Toyama, Toyama, 930-0859, Japan

  • Novartis Investigative Site

    Tanabe, Wakayama, 646-8588, Japan

  • Novartis Investigative Site

    Kofu, Yamanashi, 400-8506, Japan

  • Novartis Investigative Site

    Fukushima, 9601295, Japan

  • Novartis Investigative Site

    Ishikawa, 9208641, Japan

  • Novartis Investigative Site

    Kagoshima, 892-0853, Japan

  • Novartis Investigative Site

    Kyoto, 604-8845, Japan

  • Novartis Investigative Site

    Kyoto, 6068507, Japan

  • Novartis Investigative Site

    Niigata, 9518520, Japan

  • Novartis Investigative Site

    Okayama, 7008558, Japan

  • Novartis Investigative Site

    Osaka, 542-0081, Japan

  • Novartis Investigative Site

    Shizuoka, 422-8527, Japan